1 Min Read
April 27 (Reuters) - U.S. FDA:
* FDA expands approved use of Stivarga to treat liver cancer
* The FDA granted the approval of Stivarga to Bayer Healthcare Pharmaceuticals Inc Source text (bit.ly/2pDo2pY) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.